0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Suetonia C. Palmer, PhD; Dimitris Mavridis, PhD; Antonio Nicolucci, MD; et al.
JAMA. 2016;316(3):313-324. doi:10.1001/jama.2016.9400.
Includes: Supplemental Content

Editorial | 
David D. Waters, MD; Priscilla Y. Hsue, MD; Sripal Bangalore, MD, MHA
JAMA. 2016;315(15):1571-1572. doi:10.1001/jama.2016.3670.

Viewpoint | 
Laura Rothstein, JD
JAMA. 2015;313(22):2219-2220. doi:10.1001/jama.2015.4602.

From the JAMA Network | 
Mark Olfson, MD, MPH
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743.

Viewpoint | 
Connie B. Newman, MD; Jonathan A. Tobert, MD, PhD
JAMA. 2015;313(10):1011-1012. doi:10.1001/jama.2015.1335.

JAMA Clinical Challenge | 
Hsien-Yi Chiu, MD; Nai-Lun Yeh, MD
JAMA. 2014;312(21):2281-2282. doi:10.1001/jama.2014.13029.

The Art of JAMA | 
Carrie A. Butt
JAMA. 2014;312(17):1722-1723. doi:10.1001/jama.2013.279811.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(12):1180-1181. doi:10.1001/jama.2013.279741.

The Art of JAMA | 
Thomas B. Cole, MD, MPH
JAMA. 2014;312(7):680-681. doi:10.1001/jama.2013.279671.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;312(4):327. doi:10.1001/jama.2014.9148.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Capecitabine and the Risk of Fingerprint Loss
Leni van Doorn, MSc; Sebastiaan Veelenturf, MSc; Lisette Binkhorst, PharmD, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Medication Review After a Fracture—Absolutely Essential
Sarah D. Berry, MD, MPH; Douglas P. Kiel, MD, MPH
JAMA Internal Medicine
Original Investigation  | 
Patterns of Prescription Drug Use Before and After Fragility Fracture
Jeffrey C. Munson, MD, MSCE; Julie P. W. Bynum, MD, MPH; John-Erik Bell, MD, MS; et al.
JAMA Oncology
Original Investigation  | 
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.